A Smartphone Physical Activity App for Patients in Alcohol Treatment: Single-Arm Feasibility Trial.
A Smartphone Physical Activity App for Patients in Alcohol Treatment: Single-Arm Feasibility Trial.
复制标题
DOI：
10.2196/35926
复制
发表时间：
2022-10-19
影响因子：
2.2
通讯作者：
Stein, Michael
中科院分区：
文献类型：
--
作者：
Abrantes, Ana M.;Meshesha, Lidia Z.;Blevins, Claire E.;Battle, Cynthia L.;Lindsay, Clifford;Marsh, Eliza;Feltus, Sage;Buman, Matthew;Agu, Emmanuel;Stein, Michael
酒精使用障碍（AUD）是世界范围内一个重要的公共卫生问题。在美国，饮酒是导致死亡的主要原因，对个人和社会都有重大的负面影响。治疗后复发是常见的，辅助干预方法，以改善早期康复期间的酒精结果仍然是至关重要的。注重增加身体活动（PA）的干预措施可能改善AUD的治疗结果。鉴于智能手机和活动追踪器的普及，将这项技术集成到移动应用程序中可能是一种可行的、可接受的、可扩展的方法，可以增加AUD患者的PA。本研究旨在测试为AUD患者开发的Fit&Sober应用程序。该应用程序的目标是促进对PA参与、日常情绪和酒精渴望的自我监测，提高对PA对情绪和渴望的直接益处的认识，鼓励设定和调整PA目标，为增加PA提供资源和知识，并作为酒精复发预防策略的资源。为了对Fit&Sober app进行初步测试，我们对康复早期AUD患者进行了一项开放的先导试验（N=22; 13/22，女性59%，平均年龄43.6岁，SD 11.6岁）。入院时，参与者在过去3个月中有72%的时间饮酒，平均每个饮酒日饮酒9杯。检查Fit&Sober应用程序在AUD患者早期康复期间的可行性和可接受程度。在使用应用程序12周后，还检查了饮酒量、PA、焦虑、抑郁、酒精渴望和生活质量的变化。参与者对Fit&Sober应用程序的满意度很高。应用程序元数据表明，在干预结束时，参与者每周仍使用该应用程序约2.5天。前后分析显示对PA的增加有小到中度的影响，从基线时每天5784步（SD 2511）增加到12周时每天7236步（SD 3130） （Cohen d=0.35）。在戒断天数百分比（Cohen d=2.17）和生活质量（Cohen d=0.58）以及焦虑（Cohen d= - 0.71）和抑郁症状（Cohen d= - 0.58）的减少方面观察到中等到较大的影响。Fit&Sober应用程序是一种可接受且可行的方法，用于增加AUD患者在早期恢复期间的PA。未来有必要进行随机对照试验，以确定Fit&Sober应用程序在长期维持PA、辅助心理健康和酒精预后方面的功效。如果Fit&Sober应用程序的功效能够得到证实，AUD患者将拥有传统酒精治疗的宝贵辅助手段，可以在任何环境和任何时间提供，从而改善这一人群的整体健康和福祉。ClinicalTrials.gov NCT02958280;https://www.clinicaltrials.gov/ct2/show/NCT02958280
Alcohol use disorder (AUD) is a significant public health concern worldwide. Alcohol consumption is a leading cause of death in the United States and has a significant negative impact on individuals and society. Relapse following treatment is common, and adjunct intervention approaches to improve alcohol outcomes during early recovery continue to be critical. Interventions focused on increasing physical activity (PA) may improve AUD treatment outcomes. Given the ubiquity of smartphones and activity trackers, integrating this technology into a mobile app may be a feasible, acceptable, and scalable approach for increasing PA in individuals with AUD. This study aims to test the Fit&Sober app developed for patients with AUD. The goals of the app were to facilitate self-monitoring of PA engagement and daily mood and alcohol cravings, increase awareness of immediate benefits of PA on mood and cravings, encourage setting and adjusting PA goals, provide resources and increase knowledge for increasing PA, and serve as a resource for alcohol relapse prevention strategies. To preliminarily test the Fit&Sober app, we conducted an open pilot trial of patients with AUD in early recovery (N=22; 13/22, 59% women; mean age 43.6, SD 11.6 years). At the time of hospital admission, participants drank 72% of the days in the last 3 months, averaging 9 drinks per drinking day. The extent to which the Fit&Sober app was feasible and acceptable among patients with AUD during early recovery was examined. Changes in alcohol consumption, PA, anxiety, depression, alcohol craving, and quality of life were also examined after 12 weeks of app use. Participants reported high levels of satisfaction with the Fit&Sober app. App metadata suggested that participants were still using the app approximately 2.5 days per week by the end of the intervention. Pre-post analyses revealed small-to-moderate effects on increase in PA, from a mean of 5784 (SD 2511) steps per day at baseline to 7236 (SD 3130) steps per day at 12 weeks (Cohen d=0.35). Moderate-to-large effects were observed for increases in percentage of abstinent days (Cohen d=2.17) and quality of life (Cohen d=0.58) as well as decreases in anxiety (Cohen d=−0.71) and depression symptoms (Cohen d=−0.58). The Fit&Sober app is an acceptable and feasible approach for increasing PA in patients with AUD during early recovery. A future randomized controlled trial is necessary to determine the efficacy of the Fit&Sober app for long-term maintenance of PA, ancillary mental health, and alcohol outcomes. If the efficacy of the Fit&Sober app could be established, patients with AUD would have a valuable adjunct to traditional alcohol treatment that can be delivered in any setting and at any time, thereby improving the overall health and well-being of this population. ClinicalTrials.gov NCT02958280; https://www.clinicaltrials.gov/ct2/show/NCT02958280
登录
查看更多内容
影响因子：
25.8
作者：
Grant BF;Goldstein RB;Saha TD;Chou SP;Jung J;Zhang H;Pickering RP;Ruan WJ;Smith SM;Huang B;Hasin DS
通讯作者：
Hasin DS
影响因子：
5
作者：
Garnett, Claire;Perski, Olga;Brown, Jamie
通讯作者：
Brown, Jamie
DOI：
10.1111/j.1530-0277.1999.tb04349.x
发表时间：
1999-08-01
影响因子：
3.2
作者：
Flannery, BA;Volpicelli, JR;Pettinati, HM
通讯作者：
Pettinati, HM
影响因子：
4.7
作者：
Direito, Artur;Tooley, Mark;Maddison, Ralph
通讯作者：
Maddison, Ralph
影响因子：
4.2
作者：
Aharonovich, E;Nunes, E;Hasin, D
通讯作者：
Hasin, D